Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.757 USD | -0.64% | -3.16% | +2.11% |
2023 | NGM Biopharmaceuticals Says Phase 2b Trial of Potential Cirrhosis Treatment Meets Primary Endpoint | MT |
2023 | Alpine 4 Holdings, Inc.(NasdaqCM:ALPP) dropped from S&P Global BMI Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.11% | 20.58M | |
+0.77% | 102B | |
-0.45% | 29.9B | |
+8.72% | 21.89B | |
-10.01% | 18.96B | |
-7.58% | 17.55B | |
-2.11% | 14.03B | |
-10.83% | 11.64B | |
-4.42% | 10.34B | |
-8.88% | 10.05B |
- Stock Market
- Equities
- ALPP Stock
- News Alpine 4 Holdings, Inc.
- Alpine 4 Holdings Subsidiary Developing 'Bully Class' of Infiltration, Anti-Airspace Drones